Kuniaki Kaga
Director/Board Member bij NXERA PHARMA CO., LTD.
Oorsprong van het eerstegraads netwerk van Kuniaki Kaga
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Biotechnology | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Kuniaki Kaga via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
| INDIVIOR PLC | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Bath | College/University | Undergraduate Degree | |
| NITTO DENKO CORPORATION | Electronic Equipment/Instruments | Director/Board Member | |
| DAIWA HOUSE INDUSTRY CO., LTD. | Homebuilding | Director/Board Member | |
| AVEX INC. | Commercial Printing/Forms | Director/Board Member | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| NIPPON SHIKIZAI, INC. | Household/Personal Care | Director/Board Member | |
| BANK OF JAPAN | General Government | Corporate Officer/Principal | |
| NEC FIELDING LTD | Information Technology Services | Corporate Officer/Principal | |
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| Keio University | College/University | Graduate Degree | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
| Cranfield University | College/University | Masters Business Admin | |
| The University of Sheffield | College/University | Undergraduate Degree | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
| University of Tokyo | College/University | Graduate Degree Doctorate Degree | |
| London Business School | College/University | Masters Business Admin | |
TMI Associates
 TMI Associates Miscellaneous Commercial ServicesCommercial Services TMI Associates is a general law office based in Tokyo, Japan. The Japanese company specializes in areas of dispute and corporate fields. It is composed of lawyers, patent attorneys, and staff with experience in both domestic and public relations work. TMI Associates has established a system that can respond to a wide range of needs through partnerships with various specialized organizations. The private company was founded by Tomohiro Toyama. | Miscellaneous Commercial Services | Founder | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Mizuho Securities Co., Ltd. (Broker)
 Mizuho Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Mizuho Securities Co., Ltd. (Broker) (Mizuho Securities-Broker) is the brokerage division of Mizuho Securities Co. Ltd., ultimately owned by Mizuho Financial Group, Inc. (TYO: 8411; NYSE: MFG) in Japan. The firm was originally founded in 1917 and is headquartered in Tokyo with a network of offices throughout Japan as well as overseas representation through Mizuho entities or strategic partners (in Great Britain, Switzerland, the US, Hong Kong, Mainland China, South Korea, Singapore and India). Mizuho Securities-Broker provides enhanced equity and fixed income execution services for their clients who includes private individuals in Japan, domestic and foreign institutions, non-financial companies, financial institutions and public corporations in the securities and investment banking fields. | Investment Banks/Brokers | Analyst-Equity | |
Marunouchi Capital Co., Ltd.
 Marunouchi Capital Co., Ltd. Investment ManagersFinance Marunouchi Capital Co., Ltd. (Marunouchi Capital) is a private equity firm headquartered in Tokyo, Japan. The firm was founded in 2008 by Mitsubishi Corp. and Mitsubishi UFJ Securities Co., Ltd. | Investment Managers | Private Equity Analyst | |
| WORLD CO., LTD. | Apparel/Footwear | Director/Board Member | |
| Kumamoto University | College/University | Doctorate Degree | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Kyoto Prefectural University of Medicine | College/University | Doctorate Degree | |
cosme next Co., Ltd.
 cosme next Co., Ltd. Advertising/Marketing ServicesCommercial Services cosme next Co., Ltd. engages in the planning, development and management of cosmetics retailing business. The company was founded on January 4, 2007 and is headquartered in Tokyo, Japan. | Advertising/Marketing Services | Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| Baines Peter Consulting | Director/Board Member | ||
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Founder | |
| ERGOMED | Miscellaneous Commercial Services | Director/Board Member | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder Chief Operating Officer | |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member Director/Board Member | |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chairman | |
| Apterna Ltd. | Director/Board Member Director/Board Member | ||
Idorsia Pharmaceuticals Japan Ltd.
 Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a private company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
| Yanai Tadashi Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
| Xnef, Inc. | Director/Board Member | ||
| Koishikawa Tokyo Hospital | Corporate Officer/Principal | ||
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 20 |
| Japan | 19 |
| Verenigde Staten | 6 |
| India | 5 |
| Australië | 3 |
Sectoraal
| Health Technology | 17 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 7 |
| Consumer Non-Durables | 3 |
Operationeel
| Director/Board Member | 83 |
| Corporate Officer/Principal | 28 |
| Independent Dir/Board Member | 27 |
| Chairman | 13 |
| Chief Tech/Sci/R&D Officer | 12 |
Sterkste connecties
| Insiders | |
|---|---|
| Declan Doogan | 28 |
| Julia Gregory | 22 |
| Peter Bains | 19 |
| David Roblin | 15 |
| Rolf Soderstrom | 10 |
| Noriaki Nagai | 9 |
| Tomohiro Toyama | 5 |
| Kieran Johnson | 5 |
| Chris Cargill | 4 |
| Satoshi Tanaka | 4 |
| Miwa Seki | 4 |
| Taro Ueno | 4 |
| Shinichi Tamura | 4 |
| Hironoshin Nomura | 3 |
| Kazuhiko Yoshizumi | 3 |
- Beurs
- Insiders
- Kuniaki Kaga
- Bedrijfsconnecties
